NIH to Launch Massive ACTIV-6 Phase 3 Clinical Study
COVID-19: Osaka University artificially synthesizes mutant virus: shortened to 2 weeks
COVID-19: Chinese vaccine, suggesting low efficacy: CCDC / Gao Fu
COVID-19: Kyoto University discovers new corona drug candidate: raloxifene and pioglitazone
FUJIFILM: Established CDMO in North Carolina: Base for biopharmacy